model updat still best sidelin
analyst certif import disclosur see
model updat still best sidelin
follow nwl earn report morn adjust estim lower reflect latest think ahead print expect
see return posit core sale growth manag guidanc suggest outcom less like base
mute forecast believ share fairli valu ep estim view valuat appropri given
continu top-lin challeng on-going uncertainti long-term earn power remain busi
sustain growth resourc optim
beat adj ebitda/ consensu guid line reaffirm target doubl
come high level execut record throughput solid cost contain note similar level oper
excel could requir overcom commod headwind last materi contract transit sever
year said believ manag initi optim portfolio improv asset product metal process
profil wast tap support target organ ebitda growth modestli increas ebitda estim see
multipl catalyst relat lt growth initi maintain price target
report revs/ep vs consensu rev declin y/i tough comp ep beat came
one-tim tax benefit book rose y/i sequenti continu trubridg strength seq y/i though total
book y/i given book declin trim rev adj ep
rose cost synergi expect encourag net new instal expect bracket
amid physician dissatisfact exist offer traction cpsi ntrust saa offer continu trubridg strength
seladelpar ppar agonist receiv breakthrough therapi design btd pbc post urso view fda design
recognit pbc seriou condit new treatment still urgent need despit use urso oca valid
data qualiti seladelpar previous receiv ema prioriti medicin prime design eu equival breakthrough therapi
design pivot enhanc studi enrol view pbc opportun post urso failur crowd ocaliva
sever molecul develop seladelpar elafibranor gnft bezafibr other consequ
believ first-in-class compound chanc pbc go forward btd addit valid seladelpar profil
earlier morn report result essenti line expect sale growth improv sequenti
remain neg territori manag also introduc guidanc expect compani continu expect core sale
growth declin would view disappoint light easi comparison await confer call see whether
conservat embed rang addit impli ebit guid per calcul came shi
forecast expect also consist share trade double-digit morn
await confer call updat divestitur answer key model question
